Marinus Pharma CS
(MRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,184 | 64,676 | 104,253 | 120,572 | 140,437 |
| Marketable Securities | N/A | N/A | 9,000 | 29,716 | 35,919 |
| Receivables | 3,840 | 3,435 | 3,513 | 3,799 | 4,281 |
| Inventories | 6,717 | 4,873 | 5,783 | 2,413 | 2,736 |
| TOTAL | $57,401 | $81,882 | $131,276 | $165,246 | $195,040 |
| Non-Current Assets | |||||
| PPE Net | 4,882 | 3,720 | 3,735 | 3,843 | 3,909 |
| Other Non-Current Assets | 1,341 | 1,481 | 2,339 | 1,819 | 1,857 |
| TOTAL | $6,223 | $5,201 | $6,074 | $5,662 | $5,766 |
| Total Assets | $63,624 | $87,083 | $137,350 | $170,908 | $200,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,163 | 2,849 | 2,511 | 2,211 | 1,901 |
| Accounts payable and accrued liabilities | 3,707 | 6,237 | 6,125 | 4,003 | 2,626 |
| Accrued Expenses | 14,159 | 15,231 | 18,721 | 22,859 | 18,328 |
| TOTAL | $34,504 | $35,867 | $42,758 | $40,624 | $30,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,752 | 80,506 | 92,714 | 95,189 | 97,638 |
| Other Non-Current Liabilities | 18,108 | 18,055 | 18,312 | 18,330 | 18,076 |
| TOTAL | $95,860 | $98,561 | $111,026 | $113,519 | $115,714 |
| Total Liabilities | $130,364 | $134,428 | $153,784 | $154,143 | $146,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,186 | 55,084 | 54,934 | 54,643 | 54,574 |
| Common Shares | 55 | 55 | 55 | 55 | 55 |
| Retained earnings | -670,648 | -646,423 | -610,595 | -571,926 | -530,157 |
| Other shareholders' equity | 0 | 0 | 0 | -20 | -71 |
| TOTAL | $-66,740 | $-47,345 | $-16,434 | $16,765 | $54,537 |
| Total Liabilities And Equity | $63,624 | $87,083 | $137,350 | $170,908 | $200,806 |